OPERF
RGNX icon

Oregon Public Employees Retirement Fund’s Regenxbio RGNX Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,745
Closed -$113K – 1516
2024
Q3 		$113K Sell
10,745
-300
-3% -$3.66K ﹤0.01% 1494
2024
Q2 		$129K Buy
11,045
+200
+2% +$3.11K ﹤0.01% 1472
2024
Q1 		$229K Sell
10,845
-1,000
-8% -$17.8K ﹤0.01% 1389
2023
Q4 		$213K Sell
11,845
-200
-2% -$3.52K ﹤0.01% 1460
2023
Q3 		$198K Buy
12,045
+300
+3% +$5.44K ﹤0.01% 1564
2023
Q2 		$235K Sell
11,745
-400
-3% -$7.71K ﹤0.01% 1549
2023
Q1 		$230K Sell
12,145
-382
-3% -$8.45K ﹤0.01% 1547
2022
Q4 		$284K Buy
12,527
+45
+0.4% +$1.02K ﹤0.01% 1489
2022
Q3 		$330K Buy
12,482
+35
+0.3% +$1.04K ﹤0.01% 1417
2022
Q2 		$307K Sell
12,447
-1,596
-11% -$39.9K ﹤0.01% 1302
2022
Q1 		$466K Sell
14,043
-400
-3% -$11.1K ﹤0.01% 1423
2021
Q4 		$472K Buy
14,443
+488
+3% +$16.6K 0.01% 1322
2021
Q3 		$585K Sell
13,955
-100
-0.7% -$3.6K 0.01% 1248
2021
Q2 		$546K Hold
14,055
– – 0.01% 1288
2021
Q1 		$479K Buy
14,055
+1,985
+16% +$84.7K 0.01% 1335
2020
Q4 		$547K Sell
12,070
-888
-7% -$31K 0.01% 1204
2020
Q3 		$357K Buy
12,958
+300
+2% +$9.78K 0.01% 1246
2020
Q2 		$466K Buy
12,658
+300
+2% +$11.2K 0.01% 1133
2020
Q1 		$400K Hold
12,358
– – 0.01% 1116
2019
Q4 		$506K Hold
12,358
– – 0.01% 1208
2019
Q3 		$440K Buy
12,358
+200
+2% +$8.1K 0.01% 1302
2019
Q2 		$625K Buy
12,158
+498
+4% +$24.9K 0.01% 1189
2019
Q1 		$668K Buy
11,660
+211
+2% +$10.5K 0.01% 1133
2018
Q4 		$480K Buy
+11,449
New +$672K 0.01% 1243

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oregon Public Employees Retirement Fund's RGNX Position: Q4 2024 in Review

Oregon Public Employees Retirement Fund sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 10,745 shares — an estimated $113K sold.

Oregon Public Employees Retirement Fund first reported a position in RGNX in Q4 2018 and held it in 24 quarters. The position peaked at $668K in Q1 2019. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • Oregon Public Employees Retirement Fund reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 10,745 Regenxbio shares in Q4 2024, an estimated $113K.
  • Oregon Public Employees Retirement Fund first reported a position in Regenxbio in Q4 2018 and held it in 24 quarters.
  • Oregon Public Employees Retirement Fund's Regenxbio position peaked at $668K in Q1 2019.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q4 2024, filed 5 Feb 2025.